Idiopathic Macular Telangiectasia
📧 Sign up to get email alerts when something new happens for Idiopathic Macular Telangiectasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-07-23Clinical Trial Update: Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia [Phase 3]
Phase 3 trial update on intravitreal bevacizumab for idiopathic macular telangiectasia, with the study status shown as completed.